Sigyn Therapeutics™ to Present at Tomorrow’s Emerging Growth Conference
05 mars 2024 09h00 HE
|
Sigyn Therapeutics, Inc.
Live Online Presentation Scheduled at 12 pm EST on March 6th SAN DIEGO, CA, March 05, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (“Sigyn Therapeutics” or the “Company”)...
Sigyn Therapeutics™ Announces Filing of 2023 Annual Report on SEC Form 10-K
21 févr. 2024 08h45 HE
|
Sigyn Therapeutics, Inc.
SAN DIEGO, CA, Feb. 21, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – Sigyn Therapeutics, Inc. (“Sigyn Therapeutics” or the “Company”) (OTCQB: “SIGYD” – “SIGY”), a development-stage medical technology...
Sigyn Therapeutics Completes Reverse Stock Split
01 févr. 2024 18h25 HE
|
Sigyn Therapeutics, Inc.
SAN DIEGO, CA, Feb. 01, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire –Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: “SIGYD”, “SIGY”), a development-stage medical technology company,...
Sigyn Therapeutics Announces Reverse Stock Split
30 janv. 2024 08h45 HE
|
Sigyn Therapeutics, Inc.
SAN DIEGO, CA, Jan. 30, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a development-stage medical technology company, today...
Sigyn Therapeutics Releases Letter to Shareholders
04 janv. 2024 08h00 HE
|
Sigyn Therapeutics, Inc.
SAN DIEGO, CA, Jan. 04, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a development-stage medical technology company, today...
Sigyn Therapeutics Announces Appointment of Jerry DeCiccio as Chief Financial Officer
12 déc. 2023 08h30 HE
|
Sigyn Therapeutics, Inc.
SAN DIEGO, CA, Dec. 12, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a development-stage medical technology company, today...
Sigyn Therapeutics Reports Third Quarter 2023 Financial Results
14 nov. 2023 17h11 HE
|
Sigyn Therapeutics, Inc.
SAN DIEGO, CA, Nov. 14, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire –Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a development-stage medical technology company, today announces...
Sigyn Therapeutics™ Discloses PCT Patent Submission to Enhance Chemotherapy Delivery and Reduce Cancer Treatment Toxicity
04 oct. 2023 08h30 HE
|
Sigyn Therapeutics, Inc.
SAN DIEGO, CA, Oct. 04, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a development-stage medical technology company, today...
Sigyn Therapeutics to Present at Today’s Emerging Growth Conference and Tomorrow at the National Investment Bankers Association Conference
06 sept. 2023 08h00 HE
|
Sigyn Therapeutics, Inc.
SAN DIEGO, CA, Sept. 06, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB:SIGY), a medical technology company that creates blood purification...
Sigyn Therapeutics Reports Second Quarter 2023 Financial Results
14 août 2023 16h30 HE
|
Sigyn Therapeutics, Inc.
SAN DIEGO, CA, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a medical technology company that creates blood purification devices to overcome...